Arcutis Biotherapeutics, Inc. (ARQT)
31.20
-1.00
(-3.11%)
USD |
NASDAQ |
Oct 23, 16:00
31.20
0.00 (0.00%)
After-Hours: 20:00
Arcutis Biotherapeutics Market Cap : 3.918B for Oct. 23, 2026
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| October 23, 2026 | 3.918B |
| October 22, 2026 | 4.044B |
| October 21, 2026 | 4.003B |
| October 20, 2026 | 4.122B |
| October 19, 2026 | 4.005B |
| October 16, 2026 | 3.620B |
| October 15, 2026 | 3.655B |
| October 14, 2026 | 3.317B |
| October 13, 2026 | 3.277B |
| October 12, 2026 | 3.293B |
| October 09, 2026 | 3.338B |
| October 08, 2026 | 3.076B |
| October 07, 2026 | 3.036B |
| October 06, 2026 | 3.004B |
| October 05, 2026 | 3.159B |
| October 02, 2026 | 3.160B |
| October 01, 2026 | 3.176B |
| September 30, 2026 | 3.319B |
| September 29, 2026 | 3.360B |
| September 28, 2026 | 3.432B |
| September 25, 2026 | 3.381B |
| September 24, 2026 | 3.299B |
| September 23, 2026 | 3.313B |
| September 22, 2026 | 3.489B |
| September 21, 2026 | 3.260B |
| Date | Value |
|---|---|
| September 18, 2026 | 3.187B |
| September 17, 2026 | 3.323B |
| September 16, 2026 | 3.283B |
| September 15, 2026 | 2.953B |
| September 14, 2026 | 3.048B |
| September 11, 2026 | 3.000B |
| September 10, 2026 | 2.936B |
| September 09, 2026 | 2.994B |
| September 08, 2026 | 3.063B |
| September 04, 2026 | 3.002B |
| September 03, 2026 | 2.971B |
| September 02, 2026 | 2.995B |
| September 01, 2026 | 2.983B |
| August 31, 2026 | 3.010B |
| August 28, 2026 | 2.987B |
| August 27, 2026 | 3.123B |
| August 26, 2026 | 3.157B |
| August 25, 2026 | 3.122B |
| August 24, 2026 | 3.112B |
| August 21, 2026 | 3.150B |
| August 20, 2026 | 3.184B |
| August 19, 2026 | 3.323B |
| August 18, 2026 | 3.333B |
| August 17, 2026 | 3.216B |
| August 14, 2026 | 3.289B |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| ACADIA Pharmaceuticals, Inc. | 3.396B |
| Insmed, Inc. | 20.39B |
| Emergent BioSolutions, Inc. | 319.60M |
| Exelixis, Inc. | 16.06B |
| Puma Biotechnology, Inc. | 563.15M |
Market Cap Related Metrics
| PE Ratio | 150.65 |
| PS Ratio | 8.973 |
| Price to Book Value | 17.76 |
| Price to Free Cash Flow | 106.34 |
| Price | 31.20 |
| Earnings Yield | 0.66% |
| Operating PE Ratio | 121.55 |
| Normalized PE Ratio | 150.36 |